NASDAQ: TNYA
Tenaya Therapeutics Inc Stock Ownership - Who owns Tenaya Therapeutics?

Insider buying vs selling

Have Tenaya Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Whittemore TingleyChief Medical Officer2025-11-172,877$1.33
$3.83kSell
Tomohiro HigaSVP Finance2025-11-171,367$1.33
$1.82kSell
Faraz AliChief Executive Officer2025-11-173,126$1.33
$4.16kSell
Faraz AliChief Executive Officer2025-08-183,893$1.25
$4.88kSell
Faraz AliChief Executive Officer2025-08-184,920$1.25
$6.16kSell
Whittemore TingleyChief Medical Officer2025-08-181,837$1.25
$2.30kSell
Whittemore TingleyChief Medical Officer2025-08-181,608$1.25
$2.01kSell
Whittemore TingleyChief Medical Officer2025-08-181,608$1.25
$2.01kSell
Tomohiro HigaSVP Finance2025-08-18717$1.25
$898.40Sell
Tomohiro HigaSVP Finance2025-08-181,722$1.25
$2.16kSell

1 of 3

TNYA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TNYA insiders and whales buy or sell their stock.

TNYA Shareholders

What type of owners hold Tenaya Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Column Group III GP LP8.92%14,855,844$11.14MInsider
David V. Goeddel8.92%14,855,844$11.14MInsider
Column Group LLC5.65%9,400,290$7.05MInstitution
Eli Casdin3.87%6,440,829$4.83MInsider
Vanguard Group Inc3.04%5,064,857$3.80MInstitution
Millennium Management LLC2.71%4,504,592$3.38MInstitution
Blackrock Inc1.40%2,327,201$1.75MInstitution
Renaissance Technologies LLC1.01%1,678,202$1.26MInstitution
Geode Capital Management LLC0.71%1,175,535$881.65kInstitution
Euclidean Capital LLC0.61%1,015,705$761.78kInstitution

1 of 3

TNYA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TNYA20.74%23.13%Net BuyingNet Selling
SGMO18.60%9.48%Net SellingNet Selling
ORMP18.18%56.92%
CNTB2.90%0.00%
SPRO20.08%64.35%Net SellingNet Selling

Tenaya Therapeutics Stock Ownership FAQ

Who owns Tenaya Therapeutics?

Tenaya Therapeutics (NASDAQ: TNYA) is owned by 20.74% institutional shareholders, 23.13% Tenaya Therapeutics insiders, and 56.13% retail investors. Column Group III GP LP is the largest individual Tenaya Therapeutics shareholder, owning 14.86M shares representing 8.92% of the company. Column Group III GP LP's Tenaya Therapeutics shares are currently valued at $12.05M.

If you're new to stock investing, here's how to buy Tenaya Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.